Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates and calculations
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Cardiovascular devices industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Devices type trends
2.1.3 End-use trends
2.1.4 Regional trends
Chapter 3 Cardiovascular Devices Industry Insights
3.1 Industry landscape, 2018-2032
3.2 Industry ecosystem analysis
3.2.1 Vendor matrix
3.2.2 Distribution channel analysis
3.2.3 Profit margin trends
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing number of patients suffering from cardiovascular diseases
3.3.1.2 Expanding geriatric population base contributing to global cardiovascular disease burden
3.3.1.3 Rising government initiatives
3.3.1.4 Technological advancements in cardiovascular devices
3.3.1.5 Rising demand for minimally invasive procedures
3.3.2 Industry pitfalls & challenges
3.3.2.1 High risk associated with cardiac procedures
3.3.2.2 Stringent regulatory scenario
3.4 Growth potential analysis
3.4.1 By devices type
3.4.2 By end-use
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.1.1 Abbott Laboratories (St. Jude Medical)
4.1.2 AngioDynamics, Inc
4.1.3 AtriCure Inc
4.2 Competitive dashboard, 2021
4.3 Company matrix analysis, 2021
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 Cardiovascular Devices Market, By Devices Type
5.1 Key segment trends
5.2 Cardiac ablation devices
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Radiofrequency ablators
5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.3 Electric ablators
5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.4 Cryoablation devices
5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.5 Ultrasound devices
5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.6 Others
5.2.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Left atrial appendage closure devices
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Endocardial LAA closure devices
5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3 Epicardial LAA closure devices
5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Endoscopic vessel harvesting devices
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.2 EVH systems
5.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.3 Endoscopes
5.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.4 Accessories
5.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Cardiovascular Devices Market, By End-use
6.1 Key segment trends
6.2 Hospitals
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Centers ambulatory surgical
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Cardiac centers
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Others
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Cardiovascular devices Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.6 Middle East & Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
Chapter 8 Company Profiles
8.1 Abbott Laboratories (St. Jude Medical)
8.2 AngioDynamics, Inc
8.3 AtriCure Inc
8.4 Biosense Webster (Johnson & Johnson)
8.5 Boston Scientific Corporation
8.6 Biotronik SE & Co. KG
8.7 CardioFocus
8.8 Getinge AB
8.9 Japan Lifeline
8.10 Karl Storz
8.11 Lepu Medical Technology(Beijing) Co. Ltd
8.12 Lifetech Scientific
8.13 Livanova PLC
8.14 Microport Scientific Corporation
8.15 Medical Instruments Spa
8.16 Medtronic Plc
8.17 Occlutech
8.18 Saphena Medical, Inc
8.19 Stereotaxis, Inc
8.20 Terumo Corporation
